Literature DB >> 12577252

Understanding the impact of painful diabetic neuropathy.

Cristian Quattrini1, Solomon Tesfaye.   

Abstract

Painful neuropathy is a common and often distressing complication of diabetes. It has considerable impact on the social and psychological well-being of affected individuals. There are two distinct forms of painful neuropathy: an acute and self-limiting form that resolves within a year or a chronic form that can go on for years. There are now a number of drugs available for the treatment of neuropathic pain. However, some may fail to respond to these drugs or may have unacceptable adverse side effects. When this is the case, the patient's quality of life can be severely affected. Health care professionals need to assess the full impact of painful neuropathy. In this article we review a number of instruments that are used to assess the severity of painful neuropathy and its impact on the quality of life. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12577252     DOI: 10.1002/dmrr.360

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  33 in total

1.  The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy.

Authors:  C J Currie; C D Poole; A Woehl; C Ll Morgan; S Cawley; M D Rousculp; M T Covington; J R Peters
Journal:  Diabetologia       Date:  2006-08-30       Impact factor: 10.122

Review 2.  Painful diabetic neuropathy.

Authors:  S Tesfaye; P Kempler
Journal:  Diabetologia       Date:  2005-05       Impact factor: 10.122

3.  [Effectiveness and time to onset of pregabalin in patients with neuropathic pain].

Authors:  R Freynhagen; P Busche; C Konrad; M Balkenohl
Journal:  Schmerz       Date:  2006-08       Impact factor: 1.107

Review 4.  Diabetic neuropathic pain: Physiopathology and treatment.

Authors:  Anne K Schreiber; Carina Fm Nones; Renata C Reis; Juliana G Chichorro; Joice M Cunha
Journal:  World J Diabetes       Date:  2015-04-15

Review 5.  Central nervous system involvement in diabetic neuropathy.

Authors:  Dinesh Selvarajah; Iain D Wilkinson; Jennifer Davies; Rajiv Gandhi; Solomon Tesfaye
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

6.  Burden of Illness of Diabetic Peripheral Neuropathic Pain: A Qualitative Study.

Authors:  Meryl Brod; Betsy Pohlman; Steven I Blum; Abhilasha Ramasamy; Robyn Carson
Journal:  Patient       Date:  2015-08       Impact factor: 3.883

Review 7.  The Eurodiab study: what has this taught us about diabetic peripheral neuropathy?

Authors:  Solomon Tesfaye; Dinesh Selvarajah
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

Review 8.  An evidence-based algorithm for the treatment of neuropathic pain.

Authors:  Nanna B Finnerup; Marit Otto; Troels S Jensen; Søren H Sindrup
Journal:  MedGenMed       Date:  2007-05-15

9.  Early loss of peptidergic intraepidermal nerve fibers in an STZ-induced mouse model of insensate diabetic neuropathy.

Authors:  Megan S Johnson; Janelle M Ryals; Douglas E Wright
Journal:  Pain       Date:  2008-08-30       Impact factor: 6.961

10.  Diabetes-induced chemogenic hypoalgesia is paralleled by attenuated stimulus-induced fos expression in the spinal cord of diabetic mice.

Authors:  Megan S Johnson; Janelle M Ryals; Douglas E Wright
Journal:  J Pain       Date:  2007-05-29       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.